No Prescription |
 |
 | ||
|
Acnecinamide PHA 10 Gel Generic NIACINAMIDE |
|
| ||
No Prescription » Prescription Drugs 1 » Acnecinamide PHA 10 Gel Generic NIACINAMIDE Acne free and smooth skin with Poly Hydroxy Acids 1. Dispels acne lesions and blackheads 2. Is effective against acne spots and scars 3. Controls excessive oil and sebum production 4. Cares for the moisture balance of the skin 5. Strengthens the skin texture 6. Gives a smooth and healthy looking to the skin 7. Refreshes and regenerates the skin. Acnecinamide PHA 10 Gel Clears your complexion by removing acne lesions. Acnecinamide PHA 10 Gel is the only product that combines polyhydroxy acids (Gluconalactone lactobionic acid) with the acne fighter vitamin B3 (Niacinamide) and skin caring pro-vitamin B5 (Dexpanthenol) and beta glucone. This powerful combination helps clear up your complexion by removing pimples blemishes redness and acne-spots. Poly hydroxy acids which are more effective and less irritanting than alpha hydroxy acids exert moisturizing activity. 10 % poly hydroxy acids are composed of gluconolactone (8 %) and lactobionic acid (2 %). PHAs gently peel moisturise and hydrate the skin while rejuvenating it. Niacinamide or vitamin B3 is the best known compound that prevents excessive oil production redness and removes acne-spots. Provitamin B5 or dexpanthenol hydrates and rejuvenates the skin. Beta glucane is a plant origin compound that both hydrates and soothes the skin. The gently peeling and moisturizing ability of the Acnecinamide PHA 10 Gel removes excessive oil rejuvenates and sooths the skin. The gel can be used for all skin types.Direction: After cleaning the face Acnecinamide PHA 10 Gel is applied 2 or 3 times in a day on oily skin areas with acne and blackheads. Buy Acnecinamide PHA 10 Gel Generic NIACINAMIDE and other Prescription Drugs 1 products online at Medstore. 5794
About Acnecinamide PHA 10 Gel Generic NIACINAMIDE: Product Type: Prescription Drugs 1 Acnecinamide PHA 10 Gel (Generic NIACINAMIDE (VITAMIN B3)) Acnecinamide PHA 10 Gel (Generic NIACINAMIDE) Generic NIACINAMIDE 4% 30oz Generic NIACINAMIDE Acnecinamide PHA 10 Gel
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
